Ramon Salazar (@ramonsalazars) 's Twitter Profile
Ramon Salazar

@ramonsalazars

Medical Oncologist focused on GI cancer. Interested in new drug development, biomarker discovery & validation. Opinions are mine

ID: 273623356

calendar_today28-03-2011 21:10:39

1,1K Tweet

1,1K Followers

483 Following

Ramon Salazar (@ramonsalazars) 's Twitter Profile Photo

En GETNE (Grupo Español de tumores neuroendocrinos) presentamos los resultados del análisis multivariado del ensayo clínico fase 3 internacional SEQTOR en el congreso ESMO 2024# que empieza mañana. Os lo cuento en el Blog de Cancer Musings... prognostictools.es/blog/cancer-mu…

Ramon Salazar (@ramonsalazars) 's Twitter Profile Photo

we are presenting the results of the multivariate analysis of the Grupo GETNE international phase 3 clinical trial SEQTOR at the ESMO 2024# congress, which starts tomorrow. Read more about it on the Cancer Musings Blog... prognostictools.es/blog/cancer-mu… prognostictools.es/blog/cancer-mu…

Ramon Salazar (@ramonsalazars) 's Twitter Profile Photo

we are presenting the results of the multivariate analysis of the Grupo GETNE international phase 3 clinical trial SEQTOR at the #ESMO 2024 congress, which starts tomorrow. Read more about it on the Cancer Musings Blog... prognostictools.es/blog/cancer-mu… prognostictools.es/blog/cancer-mu…

Ramon Salazar (@ramonsalazars) 's Twitter Profile Photo

El próximo lunes lunes presentamos los resultados del análisis multivariado del ensayo clínico fase 3 internacional SEQTOR del Grupo GETNE en el congreso #ESMO 2024 que empieza mañana. Os lo cuento en el Blog de Cancer Musings... prognostictools.es/blog/cancer-mu… prognostictools.es/blog/cancer-mu…

Ramon Salazar (@ramonsalazars) 's Twitter Profile Photo

congrats to my colleagues at Institut Català d'Oncologia for their great effort and contribution to the #ESMO24 Congress. And again congrats my Grupo GETNE co-PIs for the great effort with #SEQTOR trial. Also great gratitude to all the patients involved who are the real stars

Grupo GETNE (@grupogetne) 's Twitter Profile Photo

Prime Time para Grupo GETNE con Ramon Salazar presentando la última actualización del estudio SEQTOR en #ESMO24 ‼️ La quimioterapia con STZ/5FU mejora las opciones de respuesta tumoral en pacientes con tumores G2 🔥🔥🔥

Prime Time para <a href="/GrupoGetne/">Grupo GETNE</a> con <a href="/RamonSalazarS/">Ramon Salazar</a> presentando la última actualización del estudio SEQTOR en #ESMO24 ‼️

La quimioterapia con STZ/5FU mejora las opciones de respuesta tumoral en pacientes con tumores G2 🔥🔥🔥
Ramon Salazar (@ramonsalazars) 's Twitter Profile Photo

A great thankyou to all organizers and friends of #ESMO24 congress. It was one of the best #cancer meetings ever! And it did really felt like home. All my gratitude for the warmth I felt from all the colleagues, old and new friends. We are a great community fighting #cancer

Ramon Salazar (@ramonsalazars) 's Twitter Profile Photo

estamos rodeados de datos falsos en biomedicina? Como gestionáis el ruido y sesgo? Seguidnos en #cancer musings y aquí os dejo una breve reflexion que me acaban de publicar parentesis.media/inteligencia-a…

Ramon Salazar (@ramonsalazars) 's Twitter Profile Photo

las #tesis doctorales en #Medicina no son lo que parecen...os dejo unas reflexiones a propósito de un caso, mi admirado Bernardo Queralt en mi último post del blog cancer musings prognostictools.es/blog/cancer-mu…

Ramon Salazar (@ramonsalazars) 's Twitter Profile Photo

Not all Liver Metastases from colorectal cancer are born equal, here is my commentary to an excellent paper of Dr. David Garcia Molleví from Institut Català d'Oncologia IDIBELL , with very interesting potential insights for personalized inmune therapies prognostictools.es/blog/cancer-mu…

Ramon Salazar (@ramonsalazars) 's Twitter Profile Photo

“Science is one of the very few human activities – perhaps the only one – where errors are systematically criticized and fairly often, in time, corrected.” —Karl Popper prognostictools.es/blog/cancer-mu…

Ramon Salazar (@ramonsalazars) 's Twitter Profile Photo

os dejo en nuestro blog Cancer Musings una reflexión tardía y reposada sobre la DANA y los sesgos cognitivos prognostictools.es/blog/cancer-mu… que pensáis? what are your thoughts?

Ramon Salazar (@ramonsalazars) 's Twitter Profile Photo

Precision medicine has strong limitations We must adapt as cancer evolves. Read more in my latest Cancer Musings post: 👉 prognostictools.es/blog/cancer-mu… #CancerMusings #PrecisionMedicine #Oncology #TumorHeterogeneity #CancerResearch

Ramon Salazar (@ramonsalazars) 's Twitter Profile Photo

My last post onThe Three Laws of Cancer—Complexity, Heterogeneity & Plasticity. Rethinking precision oncology beyond static biomarkersAI’s pitfalls bias, overfitting & reproducibility issues. Read more 👉 prognostictools.es/blog/cancer-mu… #CancerMusings #PrecisionMedicine #AI #Oncology

Ramon Salazar (@ramonsalazars) 's Twitter Profile Photo

Visit our Cancer Musings blog to bridge the gap between medical research and epistemological inquiry. We're not just another blog—we're a journey into the heart of cancer clinical science. #CancerResearch #MedicalPhilosophy #Oncology #ScientificThinking search.app/M13gtc2jBZKU4F…

Institut Català d'Oncologia (@ico_oncologia) 's Twitter Profile Photo

"La intuición es una herramienta esencial en medicina, pero deber ser cultivada y utilizada con responsabilidad para garantizar los mejores resultados" ho explica Ramon Salazar, cap d'#Oncologia Mèdica a l'#ICO l'Hospitalet a l'article de EL PAÍS 👇 elpais.com/salud-y-bienes…

Ramon Salazar (@ramonsalazars) 's Twitter Profile Photo

New on Cancer Musings: Biomarkers, Bias & the Burden of Proof in Precision Oncology 🧬⚖️ Why do biomarkers simplify what cancer refuses to? 💡 Bayesian models & emerging tools Full post 👉 prognostictools.es/blog/cancer-mu… #Biomarkers #CancerMusings #AI #RCTs #BayesianMedicine